Klaire Labs

Mag-Potassium Aspartate

F
N+ Score38
Vitamins & MineralsServing: 1 Tablet(s)Type: Multi-Vitamin and Mineral (MVM)

Klaire Labs Mag-Potassium Aspartate is a targeted mineral supplement containing just three ingredients. It provides 100mg of Magnesium, which is at a clinically studied dose, alongside 100mg of Potassium. However, the Potassium dosage is considered underdosed, supplying only 2% of the Daily Value. The product received an N+ Score of 38, resulting in an 'F' grade, indicating poor overall quality according to Nutrienting.com's standards. While it boasts 100% label transparency, its formula completeness is 0%, suggesting a very narrow focus. This supplement may be considered by those specifically looking to supplement Magnesium, with the understanding that Potassium is not provided at a clinically effective dose.

About This Product

Mag-Potassium Aspartate by Klaire Labs is a vitamins & minerals supplement containing 3 active ingredients. It has earned an N+ Score of 38/100 (Grade F).

Notable clinical-dose ingredients include Magnesium.

N+ Score Breakdown

Ingredient Adequacy25/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity48/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • Several ingredients below clinically effective doses
  • Missing several expected ingredients for its category

Ingredient Analysis (3 ingredients)

IngredientAmountDose Adequacy
Magnesium100.000 mgAdequate
Potassium100.000 mgUnder
Aspartic Acid400.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.